DROTAVERINE HYDROCHLORIDE VERSUS HYOSCINE BUTYLBROMIDE IN REDUCING FIRST STAGE OF LABOUR AMONG NULLIPARAE : A RANDOMIZED CONTROLLED TRIA
- Conditions
- Pregnancy and Childbirth
- Registration Number
- PACTR202206902932545
- Lead Sponsor
- nenna S Nweke
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 165
1.Nulliparae
2.Women who consented to participate in the study
3.Women with fetus in cephalic presentation
4.Singleton fetus with no evidence of maternal or fetal distress.
5.Women with no contraindication to vaginal delivery.
6.Term pregnancies with intact or ruptured membranes
7.Cervical dilatation of 4-5 cm only
8.Spontaneous or induced labour
9.Patients on epidural
1 Women with abnormal fetal presentation.
2. Women in latent phase of labour.
3. Preterm / term premature rupture of membranes.
4. Antepartum haemorrhage.
5. Those who refused to consent.
6. Previous uterine scar or surgery.
7. Huge fibroid in pregnancy.
8. Multiple gestations.
9. Multiparous or grand multiparous patients.
10. Medical diseases in pregnancy such as severe preeclampsia/eclampsia and others.
11. History of cervical surgery.
12. Hypersensitivity to drotaverine hydrochloride.
13. Any contraindication to vaginal delivery
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.